Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
34.2K
-
Shares change
-
+34.2K
-
Total reported value, excl. options
-
$37.3K
-
Value change
-
+$37.3K
-
Number of buys
-
1
-
Price
-
$1.09
Significant Holders of Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share (OTLK) as of Q1 2023
1 filing reported holding OTLK - Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q1 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.